HORMONE THERAPY & PUBERTY BLOCKER PROTECTION

HB 466, the "Hormone Therapy and Puberty Blocker Child Protection Act," prohibits health care providers and public bodies from knowingly performing or administering hormone therapy or puberty blockers to minors for the purpose of helping them live as a gender different from their sex assigned at birth, except for treating congenital defects, precocious puberty, or existing medical conditions ending by December 2025. The bill requires health care providers to notify parents in writing before a minor receives gender-affirming care, defines "gender-affirming action" broadly to include name/pronoun changes or seeking related services, and overrides minors' ability to consent to such care. It also creates a private right of action for parents to sue providers or public bodies for violations. The bill was referred to committees in February 2025 but was postponed indefinitely on June 3, 2025.